Will the speed of COVID-19 vaccine development reset industry norms?
New drugs and vaccines typically take several years to hit the market. In fact, the average time to develop a drug or vaccine has been eight to ten years — until recently. In a new analysis, McKinsey reviews what it took to shorten that timeline to less than a year. It examines the funding, operational, technological, and regulatory factors that allowed for fast development of Covid-19 vaccines, revealing which variables will remain relevant for future efforts — and which won’t.